129 related articles for article (PubMed ID: 16546726)
1. [Adenovirus-mediated delivery of targeted ribonuclease against HBV replication in vitro].
Gong WD; Lei P; Zhao Y; Liu J; Xue CF
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Mar; 26(3):279-83. PubMed ID: 16546726
[TBL] [Abstract][Full Text] [Related]
2. Anti-HBV activity of TRL mediated by recombinant adenovirus.
Gong WD; Zhao Y; Yi J; Ding J; Liu J; Xue CF
World J Gastroenterol; 2005 May; 11(17):2574-8. PubMed ID: 15849814
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of HBV targeted ribonuclease enhanced by introduction of linker.
Gong WD; Liu J; Ding J; Zhao Y; Li YH; Xue CF
World J Gastroenterol; 2003 Jul; 9(7):1504-7. PubMed ID: 12854151
[TBL] [Abstract][Full Text] [Related]
4. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
5. Adenoviral-vector mediated transfer of HBV-targeted ribonuclease can inhibit HBV replication in vivo.
Zhao Y; Li Y; Liu J; Liu Z; Huang Y; Lei J; Li S; Xue C
Biochem Biophys Res Commun; 2008 Jul; 371(3):541-5. PubMed ID: 18455508
[TBL] [Abstract][Full Text] [Related]
6. [Construction of replication-deficient recombinant adenoviral vector carrying HBsAg and HSP70 chimeric gene and its expression in vitro].
Lei CL; Huang CH; Yang Z; Tang XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):136-9. PubMed ID: 18574539
[TBL] [Abstract][Full Text] [Related]
7. [Expression of HBV preS2/S gene in mammalian cells transferred with adenoviral vector].
Lei CL; Huang CH; Yang Z; Tang XP
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2005 Mar; 19(1):55-7. PubMed ID: 16201475
[TBL] [Abstract][Full Text] [Related]
8. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
[TBL] [Abstract][Full Text] [Related]
9. [Transfection of siRNA expressing plasmids targeting S gene inhibits replication and expression of hepatitis B virus in hepatic cancer cells].
Bian ZQ; Cui ZL; Chen WZ; Liu MQ; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(5):347-51. PubMed ID: 19563716
[TBL] [Abstract][Full Text] [Related]
10. [Construction and expression of prokaryotic expression vector for pTAT-HBV targeted ribonuclease fusion protein].
Ding J; Liu J; Xue CF; Li YH; Gong WD
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Jan; 19(1):49-51. PubMed ID: 15132905
[TBL] [Abstract][Full Text] [Related]
11. [Adenovirus-mediated transduction of HBV/C genome into HepG2 cell line].
Zhou B; Liang MF; Li WD; Wang C; Wang ZH; Hou JL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Oct; 28(10):1764-7. PubMed ID: 18971166
[TBL] [Abstract][Full Text] [Related]
12. Targeted ribonuclease can inhibit replication of hepatitis B virus.
Liu J; Li YH; Xue CF; Ding J; Gong WD; Zhao Y; Huang YX
World J Gastroenterol; 2003 Feb; 9(2):295-9. PubMed ID: 12532452
[TBL] [Abstract][Full Text] [Related]
13. [Inhibition of HBsAg and HBeAg secretion by RNA interference of the polymerase gene sequence of hepatitis B virus: an experimental study].
Liu SA; Wei HS; Dong QM; Guo JJ; Qin J; Zhang QY; Liu ZY; Yan J; Cheng J
Zhonghua Yi Xue Za Zhi; 2005 Nov; 85(43):3079-83. PubMed ID: 16324412
[TBL] [Abstract][Full Text] [Related]
14. [Anti-HBV effects of genetically engineered replication-defective HBV with combined expression of antisense RNA and dominant negative mutants of core protein and construction of first-generation packaging cell line for HBV vector].
Sun DX; Hu DR; Wu GH; Hu XL; Li J; Fan GR
Zhonghua Gan Zang Bing Za Zhi; 2002 Aug; 10(4):260-4. PubMed ID: 12223133
[TBL] [Abstract][Full Text] [Related]
15. [Construction of recombinant replication competent plasmids containing HBV genome with mutations of precore and basic core promoter].
Wang Y; Jiang D; Wei L; Chen HS; Cong X; Fei R; Wang Y
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):218-22. PubMed ID: 15640852
[TBL] [Abstract][Full Text] [Related]
16. [Construction of recombinant eukaryotic expression plasmid containing 1.3-fold-overlength genome of HBV and its expression in HepG2 cells].
Tang N; Huang AL; Zhang BQ; Yan G; Xiang MQ; Pu D; Guo H
Zhonghua Gan Zang Bing Za Zhi; 2003 Aug; 11(8):464-6. PubMed ID: 12939176
[TBL] [Abstract][Full Text] [Related]
17. A promising alternative anti-HBV agent: the targeted ribonuclease.
Li Y; Zhao Y; Liu J; Huang Y; Liu Z; Xue C
Int J Mol Med; 2010 Jul; 26(1):51-6. PubMed ID: 20514422
[TBL] [Abstract][Full Text] [Related]
18. [Construction of a recombinant adenovirus expression vector for human renal tumor- associated antigen G250 gene with AdMax system].
Qi H
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1617-20, 1625. PubMed ID: 18819881
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy of siRNAs mediates greater suppression on hepatitis B virus cccDNA in HepG2.2.15 cell.
Xin XM; Li GQ; Guan XR; Li D; Xu WZ; Jin YY; Gu HX
Hepatogastroenterology; 2008; 55(88):2178-83. PubMed ID: 19260501
[TBL] [Abstract][Full Text] [Related]
20. [Stable expression of HBV C gene mutants in immortalized human B-cell lines].
Zhang MX; Zhou FY; Diao ZH; He HT; Hou JL; Luo KX
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Jun; 26(6):725-9. PubMed ID: 16793585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
